Central registration is the most updated ever pharma industry interesting topic. The topic has been always on the table for discussion, many times ago till it has been enforced finally in 2021.
The central registration through the Gulf Health Council "GHC" for pharmaceutical products so far, and very soon will be applicable also to medical devices.
As regulatory affairs professional you must keep up to date with the changing regulations, especially in the META region
Central registration is the most updated ever pharma industry interesting topic. The topic has been always on the table for discussion, many times ago till it has been enforced finally in 2021.
The central registration through the Gulf Health Council "GHC" for pharmaceutical products so far, and very soon will be applicable also to medical devices.
As regulatory affairs professional you must keep up to date with the changing regulations, especially in the META region
The central registration option allows you to make only one single submission, one single dossier for your product, that will be approved in all other GCC countries, so going central, means going to the whole GCC region by only one submission.
Still, you have to submit it individually to each country, but it is just admin work, and the dossier has already been revised and proven by the Gulf Health Council, so it takes 2 months instead of 1 year, does that sound great? for sure
However, soon you will not have to submit individually anymore after the central registration submission
Central registration is mandatory for the pharma industry business as it is not allowed to apply for the tenders in the GCC region unless you have central registration, those tenders cannot be missed for any company to achieve the potential ROI.
In this course, we will cover everything related to the topic of the central registration
Staring by Gulf Central Committee For Drug Registration, Human Drugs Centralized Registration Process, Module 3 insights, Company (Site/MAH) Centralized Registration, GCC Guidelines for Renewal of Marketing Authorizations, GCC Guidelines for Variation Requirements, GCC Guidelines for Variation Requirements, GCC Guidelines for Presenting the
Let us master central registration together.
An introduction to the central registration of pharmaceutical products through the Gulf Health Council "GHC" through Saudi Food and Drug Administration "SFDA" through the leader country of the whole GCC region "KSA" Kingdom of Saudi Arabia, we will discover together the structure of this course and what we are covering starting our journey by what is the "GHC", countries involved, regulations to submit for central registration, dossier preparation, submission, and afar submission, renewal, and variations across the whole GCC region.
The Gulf Health council "GHC" includes ?
A) KSA
B)Oman
C) Bahrain
D) Kuwait
E) All of the above
In this section, we will discover the vision and mission of the GHC, in addition to the step-by-step process of the central registration, time frame, different probable pathways along with their outcomes, and what to do regarding each of these outcomes.
Central Registration Process
This section will start with the GCC Data Requirements for Human Drugs Submission version 1.1, our reference guidelines for the submission, starting with the basics for the submission, that the pharmaceutical product must be submitted along with a site "manufacturing site", in addition to samples to be submitted centrally to the SFDA , and to individual countries as well, we will explore together the basic structure of the pharmaceuticals submission, which is the "CTD", how it s structured, what are the modules, and what should be included in each module.
CTD modules
In this section we will go together through module 1 in detail, explaining each and every document and its conditions of acceptance regarding legalization or not, whether a hard copy is mandatory or only a scanned copy is enough, and what if any of the documents are not ready at the submissions time/. what to do? how to proceed, in addition to examples from practice
Module 1 is so critical, is the module that you as a regulatory affairs professional will prepare, the country-specific module
Module 1 in detail
In this section, we will discover together the checklist to prepare module 2 , along with its details and comments as a core part of the CTD
Module 2 in Detail
Module 3 the most critical module ever among all other modules of the CTD, which is dealing with quality, the main focus of healthcare authorities, the module which they use as a reference for samples analysis submitted along with the dossier, it is received ready from the HQ , but need close supervision, let us discover the checklist and documents included in module 3 in detail
Module 3 in Detail
This section will explain in detail both module 4 related to the nonclinical studies and module 5 the most crucial module dealing with products safety that mandate the emergence of the relatively new profession of the pharma industry which's pharmacovigilance, this in addition to actual cases from practice
Module 4 and 5
In this section, we will highlight the important pint in module 3 and link them to actual situations from practice
In this section we will make actual submissions for the site /manufacturing site as the first basic step for the central registration for any product
Site Submission
This section will know when and how to submit for marketing authorization renewal
Renewal
Let us start our so interesting and huge part also of the course, the section which is the most applicable in the daily work , this is the core part for practice
This section will go deeper into the variation checklist discovering the documents, conditions, preparation, and submission for the central variations
In this section will continue with the variation checklist discovering the documents, conditions, preparation and submission for the central variations
In this section, we will explore the specific updated format of the PIL that set by SFDA, and approved for the whole GCC countries, which is applicable to the central registration through the Gulf Health Council
Central PIL
In this section, we will explore the specific updated format of the SMPCs that are set by SFDA, and approved for the whole GCC countries, which is applicable to the central registration through the Gulf Health Council
SMPCS
In this section, we will go to the details of the stability testing and requirements for central registration, zones of stability, and how to proceed with actual cases from practice
Stability
In this section will know about the details of storage conditions, and transportation options, that ensure the stability of products over the whole shelf life and as per storage conditions
Storage
OpenCourser helps millions of learners each year. People visit us to learn workspace skills, ace their exams, and nurture their curiosity.
Our extensive catalog contains over 50,000 courses and twice as many books. Browse by search, by topic, or even by career interests. We'll match you to the right resources quickly.
Find this site helpful? Tell a friend about us.
We're supported by our community of learners. When you purchase or subscribe to courses and programs or purchase books, we may earn a commission from our partners.
Your purchases help us maintain our catalog and keep our servers humming without ads.
Thank you for supporting OpenCourser.